We previously reported that the p38 mitogen-activated protein kinase (p38/MAPK) pathway becomes activated during infection and that inhibition of p38 reduces both inflammatory cytokine expression and SARS-CoV-2 replication, suggesting that p38 inhibition may target multiple mechanisms related to SARS-CoV-2 pathogenesis (11). This evidence concerns the gene MAPK14 and infection.